Better COVID Stock: Moderna vs. Novavax
Moderna (NASDAQ: MRNA) and Novavax (NASDAQ: NVAX) have shaken up the vaccine world over the past year. Moderna became one of the first to launch a coronavirus vaccine. Novavax may soon enter the market with its vaccine candidate. Shares of both companies soared in 2020. Moderna rose 434% and Novavax surged more than 2,700%. But the story isn't over. Gains have continued this year.
Now, you might be wondering, If I want to invest in just one coronavirus player right now, which one of these hot stocks should I choose? Let's take a look at both companies -- and consider your investing style.
Image source: Getty Images.
Source Fool.com


